Piotex Indus. (544178)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 23.93% suggests efficient capital deployment, if sustained.
• Sales growth is positive at 1.43%, showing some revenue stability.
• Latest quarter sales of ₹67 Cr provide a meaningful revenue base against a ₹41 Cr market cap.
• Stock is trading at the top of its 52-week range, indicating some market support.

Concerns

• Profit growth collapsed by 95.09% and the latest quarter net profit is ₹0 Cr.
• Piotroski F-Score of 4/9 signals weak financial health.
• PEG of 10.25 indicates the valuation is expensive relative to growth.
• Zero dividend yield and missing book value, debt, and promoter holding data limit transparency.

AI Analysis

At ₹80, Piotex Indus carries a market cap of just ₹41 Cr. As Graham would say, the first job is to avoid losing money. From the numbers in front of me, I see a business whose sales growth is a mere 1.43%, while profits have collapsed by 95.09%. The latest quarter reports sales of ₹67 Cr and net profit of ₹0 Cr. That tells me the company is currently earning nothing for shareholders. A trailing P/E of 14.66 may look reasonable, but it is backwards-looking and meaningless when current earnings are close to zero. The PEG of 10.25 makes the point sharper: the market is paying a rich price for very little growth. The Piotroski F-Score of 4 out of 9 reinforces my caution about financial health. I am also uncomfortable that book value, debt/equity, and promoter holding are not available; in a small-cap textile business, those are exactly the facts I need. The positive ROCE of 23.93% is the one bright spot, but it is not showing up in net profit or in a dividend, since the yield is zero. Mr. Market has pushed the stock to the top of its 52-week range of ₹31.67 to ₹80, but a rising price cannot create intrinsic value by itself. This may be a turnaround situation, but I do not invest in turnarounds without evidence of a clear path to profitability and a strong balance sheet. Buying here means relying on hope rather than analysis. As I always say, price is what you pay, value is what you get. Right now, the available numbers do not prove that value exists. I would stay on the sidelines until profits return or the price falls to a level with a genuine margin of safety.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer